OTCMKTS:VCKAU

Vickers Vantage Corp. I (VCKAU) Stock Forecast, Price & News

$9.60

-0.71 (-6.89%)

(As of 11/10/2022)

Compare

Today's Range: $8.61
▼
$10.15
50-Day Range: $9.60
▼
$9.60
52-Week Range: $8.61
▼
$10.94

Volume: 2,800 shs
Average Volume: 5,774 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership Headlines SEC Filings

About Vickers Vantage Corp. I (OTCMKTS:VCKAU) Stock

As of November 10, 2022, Vickers Vantage Corp. I was acquired by Scilex Holding Company, in a reverse merger transaction. Vickers Vantage Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Singapore.

Receive VCKAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vickers Vantage Corp. I and its competitors with MarketBeat's FREE daily newsletter.

VCKAU Stock News Headlines

May 31, 2023 | americanbankingnews.com

Vickers Vantage Corp. I (OTCMKTS:VCKAU) Trading Down 6.9%

May 18, 2023 | uk.investing.com

Scilex Holding Co (SCLX)

June 1, 2023 | Edge On The Street (Ad)

ChatGPT Is Already "Old School"

As good as ChatGPT is at writing content, it still doesn't understand what it's saying. But a new AI technology breakthrough will understand and process information like a human. One young company is leading the way.

May 14, 2023 | finance.yahoo.com

Sorrento Therapeutics, Inc.'s Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms to Deliver the Stock to Individual Accounts

May 4, 2023 | finance.yahoo.com

Scilex Holding Company Announces Complete Enrollment of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain

April 17, 2023 | finance.yahoo.com

Scilex Holding Company Enters into Master Distributor Agreement with CH Trading Group LLC and AD Ports Group for the Distribution of ZTlido® in the Middle East and North Africa Region

March 21, 2023 | finance.yahoo.com

Scilex Holding Company Announces Financing of up to $25 Million to Enhance Commercialization of Three FDA Approved Non-Opioid Pain Management Products

March 1, 2023 | forbes.com

Boras Corporation

June 1, 2023 | Edge On The Street (Ad)

ChatGPT Is Already "Old School"

February 18, 2023 | finance.yahoo.com

Chip Resistor Market Size & Share to Surpass $2.0 Billion by 2028 | Vantage Market Research

February 17, 2023 | finance.yahoo.com

Sorrento Issues Update to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

February 4, 2023 | finance.yahoo.com

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders

February 2, 2023 | finance.yahoo.com

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

January 5, 2023 | finance.yahoo.com

Vantage Data Centers Names Purnima Wagle as Chief Information Officer

November 10, 2022 | marketwatch.com

Vickers Vantage Shares Down 10% After Closing Scilex Deal

October 31, 2022 | finance.yahoo.com

Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on Form S-4, Date of Vickers Vantage Extraordinary General Meeting to Approve Proposed Business Combination

October 2, 2022 | uk.finance.yahoo.com

Vickers Vantage Corp. I (VCKA)

August 31, 2022 | investorplace.com

Sorrento Therapeutics (SRNE) Pops on FDA Fast Track Designation

August 24, 2022 | finance.yahoo.com

Vickers Vantage Corp. I (VCKAU)

August 17, 2022 | finance.yahoo.com

Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido® across certain designated territories including Middle East and North Africa

June 14, 2022 | finance.yahoo.com

Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US.

May 18, 2022 | finance.yahoo.com

Scilex, a Sorrento Company, Announces Initiation of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 in Subjects with Acute Low Back Pain

May 16, 2022 | finance.yahoo.com

Scilex Holding Company, a Sorrento Company, and Vickers Vantage Corp. I announced today the filing of a Registration Statement on Form S-4 with the Securities and Exchange Commission relating to the previously announced proposed business combination between Scilex and Vickers

April 27, 2022 | finance.yahoo.com

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., to Present SP-102 (SEMDEXA™) Efficacy and Safety Data from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management at the 24th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP) in Las Vegas, NV.

April 25, 2022 | finance.yahoo.com

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Expanding Its Direct Distribution Network to National And Regional Wholesalers And Pharmacies

March 25, 2022 | finance.yahoo.com

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., enters into a Non-Binding Term Sheet for a $5 Billion Committed Equity Financing Facility to be Effective in Connection with the Closing of the Merger with Vickers Vantage Corp I

March 18, 2022 | finance.yahoo.com

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Final Results for SP-102 (SEMDEXA™) Efficacy and Safety from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management Supporting the Potential for First to Market Opportunity

See More Headlines

VCKAU Price History

30 days | 90 days | 365 days | Advanced Chart

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Shell Companies
Sub-Industry: N/A
Sector: Finance
Current Symbol: OTCMKTS:VCKAU
CUSIP: N/A
CIK: 1820190
Web: www.vickersvantage.com
Phone: 646 974 8301
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Chien-Chuen Chi C.F.A. (Age 54)
Exec. Chairman & CEO

Mr. Chris Ho (Age 33)
CFO & Director

Key Competitors

View All Competitors

VCKAU Stock - Frequently Asked Questions

How have VCKAU shares performed in 2023?: Vickers Vantage Corp. I's stock was trading at $9.60 on January 1st, 2023. Since then, VCKAU shares have increased by 0.0% and is now trading at $9.60.
View the best growth stocks for 2023 here.
What is Vickers Vantage Corp. I's stock symbol?: Vickers Vantage Corp. I trades on the OTCMKTS under the ticker symbol "VCKAU."

How do I buy shares of Vickers Vantage Corp. I?: Shares of VCKAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Vickers Vantage Corp. I's stock price today?: One share of VCKAU stock can currently be purchased for approximately $9.60.
How can I contact Vickers Vantage Corp. I?: The official website for the company is www.vickersvantage.com. The company can be reached via phone at 646 974 8301.

This page (OTCMKTS:VCKAU) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial